PIK3CA and AKT1 mutations have been identified in cisplatin-resistant germ cell tumors [6,48], and phospho-AKT levels are significantly higher in cisplatin-resistant TGCTs compared with cisplatin-sensitive ones [49]. This evidence concerns the gene AKT1 and germ cell tumor.